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Items for this week’s Epi Update include: 
• Flood-related disease precautions and information 
• AAP: No influenza vaccine preference for 2019-'20 season 
• Quinidine for severe malaria no longer available, contact CDC for artesunate 
• In the news: If you're safe from cholera, thank my dad, a plumber (and thank the 
ancient Romans) 
• In the news: A gulp of genetically modified bacteria might someday treat a range 
of illnesses 
• In the news: Deaths from dementia have more than doubled in U.S., report says 
• Infographic: Cook chicken liver like it’s chicken (it is) 
• Meeting announcements and training opportunities 
 
Flood-related disease precautions and information 
Recent rains in combination with melting snow have resulted in flooding in some parts of the 
state. It is important to maintain personal hygiene in a flood situation to prevent the spread of 
germs and illnesses. Proper hand washing, bathing, clothes washing, dental hygiene, and 
wound care treatment can keep those affected by a flood safe and healthy. 
 
Food contamination can be a problem after a flood because flood water can carry mud, raw 
sewage, chemicals, and fuel. Filth and disease-causing bacteria can contaminate any food the 
water contacts and make that food unsafe to eat. Never taste food to determine its safety. If in 
doubt, throw it out. Discard any food that is not in a waterproof container if there is any chance 
that it has come into contact with flood water. 
 
People commonly ask about the risk of tetanus and hepatitis during floods. Increases in cases 
of tetanus and hepatitis have not been associated with flooding. People are at risk for tetanus 
infection when they are injured and have wounds that are contaminated by the environment. 
Flooding is not shown to increase the risk for tetanus disease. However, cleaning up after a 
flood may increase the risk of getting a wound. Injured individuals can be assessed to 
determine whether a tetanus-containing vaccine is needed. Hepatitis immunizations are 
recommended for some people based on behavioral, occupational, medical, and other risk 
factors. Hepatitis risk is not increased due to exposure to flood waters. However, floods serve 
as a good reminder to ensure patients are up to date on all recommended vaccines. Tetanus 
and hepatitis immunizations are part of the routinely recommended vaccine schedules for 
children and adults. 
 
For more information, visit idph.iowa.gov/flooding.  
 
AAP: No influenza vaccine preference for 2019-'20 season 
This week the American Academy of Pediatrics (AAP) clarified that they will no longer express 
a preference for the influenza shot over nasal spray vaccine for children during the 2019-'20 
influenza season. The recommendation comes after AAP reviewed current data on vaccine 
coverage and effectiveness and flu season characteristics. It also considered the reformulation 
of the nasal spray vaccine. 
AAP and CDC did not recommend using the nasal spray (live attenuated influenza vaccine, 
LAIV) in 2016-'17 or 2017-'18 due to poor effectiveness against H1N1 strains. LAIV 
manufacturer AstraZeneca has since changed the formulation of the vaccine to include a new 
strain (A/Slovenia) that it suggested would produce better antibody responses than the 
previous H1N1 strain (A/Bolivia). 
 
This season, AAP recommended using the influenza shot (inactivated influenza vaccine, IIV) 
as the primary vaccine choice, while saying LAIV may be used for children who would not 
otherwise receive a vaccine. CDC did not express a preference. 
 
In making a recommendation for the 2019-'20 season, AAP reviewed U.K. data showing that 
the reformulated LAIV has been effective against influenza A/H1N1 for children this season, 
when H1N1 has been the predominant circulating strain. 
 
AAP recommends universal vaccination for everyone 6 months and older. 
 
Quinidine for severe malaria no longer available, contact CDC for artesunate 
Quinidine, the only FDA-approved IV antimalarial drug used to treat severe malaria, will no 
longer be available starting April 1, 2019. At that time, IV artesunate, the WHO-recommended 
first-line treatment for severe malaria, will become the first-line drug for treatment of severe 
malaria in the U.S. Because IV artesunate is neither FDA-approved nor commercially available 
in the U.S., CDC has made IV artesunate available under an expanded access investigational 
new drug (IND) protocol.  
 
Starting April 1, all U.S. clinicians must call CDC to obtain IV artesunate to treat cases of 
severe malaria. 
 
CDC is hosting a Clinician Outreach and Communication Activity (COCA) call on Thursday, 
March 28 to review guidance for use of IV artesunate for the treatment of severe malaria.  
 
For more information, including how to join the COCA call, visit 
emergency.cdc.gov/coca/calls/2019/callinfo_032819.asp.  
 
In the news: If you're safe from cholera, thank my dad, a plumber (and thank the ancient 
Romans) 
www.usatoday.com/story/opinion/voices/2019/03/11/world-plumbing-day-water-sanitation-
public-column/3102889002/  
 
In the news: A gulp of genetically modified bacteria might someday treat a range of 
illnesses 
www.npr.org/sections/health-shots/2019/03/08/687370312/a-gulp-of-genetically-modified-
bacteria-might-someday-treat-a-range-of-illnesses  
 
In the news: Deaths from dementia have more than doubled in U.S., report says 
www.cnn.com/2019/03/14/health/dementia-deaths-study/index.html  
 
 
 
 
Infographic: Cook chicken liver like it’s chicken (it is) 
 
 
To view in full size, visit  
www.cdc.gov/nceh/ehs/docs/factsheets/chicken-liver-infographic-p.pdf.  
 
Meeting announcements and training opportunities 
The St. Louis STD/HIV Prevention Training Center will be hosting STD Update – Focus on 
Syphilis at the Scott County Administrative Building in Davenport on Friday, March 22 from 
8:30 am – 12:45 pm. This training will provide the latest information to clinicians regarding the 
epidemiology, clinical presentation, laboratory testing, and treatment related to syphilis. To 
register, visit courses.nnptc.org/register.html?id=2512.  
 
Have a healthy and happy week! 
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